Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 May 2026 | 28 Feb 2026 | 30 Nov 2025 | 31 May 2025 | 28 Feb 2025 | 30 Nov 2024 |
|---|---|---|---|---|---|---|
| Revenue | 41.46B | 23.86B | 13.64B | 9.30B | 8.05B | 8.71B |
| Cost of revenue | 6.40B | 6.11B | 6.00B | 5.79B | 5.09B | 5.36B |
| Gross profit | 35.06B | 17.76B | 7.65B | 3.51B | 2.96B | 3.35B |
| Research and development | 1.32B | 1.25B | 1.17B | 965M | 898M | 888M |
| Selling, general and administrative | 407M | 344M | 337M | 318M | 285M | 288M |
| Operating income | 33.32B | 16.14B | 6.14B | 2.17B | 1.77B | 2.17B |
| Pre-tax income | 33.21B | 16.16B | 6.06B | 2.11B | 1.76B | 2.15B |
| Income tax | 4.98B | 2.37B | 829M | 235M | 177M | 283M |
| Net income | 28.24B | 13.79B | 5.24B | 1.89B | 1.58B | 1.87B |
| Earnings per share | 25.03 | 12.25 | 4.66 | 1.69 | 1.42 | 1.68 |
| Earnings per share, diluted | 24.67 | 12.07 | 4.60 | 1.68 | 1.41 | 1.67 |
| Weighted average shares | 1.13B | 1.13B | 1.13B | 1.12B | 1.12B | 1.11B |
| Weighted average shares, diluted | 1.15B | 1.14B | 1.14B | 1.13B | 1.12B | 1.12B |
| Metric | 31 May 2026 | 28 Feb 2026 | 30 Nov 2025 | 31 Aug 2025 | 31 May 2025 | 28 Feb 2025 | 30 Nov 2024 | 31 Aug 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 25.00B | 13.91B | 9.73B | 9.64B | 10.16B | 7.56B | 6.70B | 7.05B |
| Receivables | 31.03B | 17.31B | 10.18B |
| Metric | 31 May 2026 | 28 Feb 2026 | 30 Nov 2025 | 31 May 2025 | 28 Feb 2025 | 30 Nov 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | — | 8.41B | — | — | 3.24B |
| Depreciation and amortisation | 2.36B | 2.29B | 2.21B | 2.09B |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 9.27B |
| 7.44B |
| 6.50B |
| 7.42B |
| 6.62B |
| Inventory | 8.57B | 8.27B | 8.21B | 8.36B | 8.73B | 9.01B | 8.71B | 8.88B |
| Current assets | 66.74B | 41.41B | 29.67B | 28.84B | 27.92B | 24.69B | 24.49B | 24.37B |
| Goodwill | 1.15B | 1.15B | 1.15B | 1.15B | 1.15B | 1.15B | 1.15B | 1.15B |
| Total assets | 134.11B | 101.51B | 85.97B | 82.80B | 78.40B | 73.05B | 71.46B | 69.42B |
| Current liabilities | 19.49B | 14.30B | 12.06B | 11.45B | 10.14B | 7.88B | 9.02B | 9.25B |
| Short-term debt | 582M | 585M | 569M | 560M | 538M | 504M | 533M | 431M |
| Long-term debt | 5.14B | 9.56B | 11.19B | 14.02B | 15.00B | 13.85B | 13.25B | 12.97B |
| Total liabilities | 33.39B | 29.05B | 27.17B | 28.63B | 27.65B | 24.42B | 24.66B | 24.29B |
| Equity | 100.72B | 72.46B | 58.81B | 54.17B | 50.75B | 48.63B | 46.80B | 45.13B |
| Shares outstanding | 1.13B | 1.13B | 1.13B | 1.12B | 1.12B | 1.12B | 1.11B | 1.11B |
| Shares issued | 1.28B | 1.27B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B | 1.25B |
| Treasury shares | 146M | 146M | 145M | 144M | 144M | 144M | 144M | 144M |
| 2.08B |
| 2.03B |
| Share-based compensation | — | — | 290M | — | — | 220M |
| Capital expenditure | — | — | 5.39B | — | — | 3.21B |
| Investing cash flow | — | — | −4.59B | — | — | −3.15B |
| Dividends paid | — | — | 134M | — | — | 131M |
| Share buybacks | — | — | 300M | — | — | 0 |
| Financing cash flow | — | — | −3.75B | — | — | −422M |